Article Information
History
- September 13, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alvaro Yanez Touzet1,2,#,
- Tatiana Houhou3,†,
- Zerina Rahic3,†,
- Ilya Laufer4,
- Konstantinos Margetis5,
- Allan R Martin6,
- Nicolas Dea7,
- Zoher Ghogawala8,
- Misha Kapushesky9,
- Mark R N Kotter10,11,12,
- Benjamin M. Davies13,14,‡,* and
- MoveMed
- 1School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
- 2Chief Scientific Officer, MoveMed Ltd, Cambridge, UK
- 3Division of Science, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
- 4NYU Langone Health, New York, NY USA
- 5Icahn School of Medicine at Mount Sinai, New York, NY USA
- 6Department of Neurological Surgery, University of California, Davis, CA USA
- 7Department of Surgery, University of British Columbia, Vancouver, BC, Canada
- 8Lahey Hospital and Medical Center, Burlington, MA USA
- 9Chief Data Officer, MoveMed Ltd, Cambridge, UK
- 10Chief Medical Officer, MoveMed Ltd, Cambridge, UK
- 11Department of Clinical Neurosurgery, University of Cambridge, Cambridge, UK
- 12Department of Clinical Neurosciences, Ann McLaren Laboratory of Regenerative Medicine, Cambridge, UK
- 13Chief Executive Officer, MoveMed Ltd, Cambridge, UK
- 14Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- ↵*Correspondence to:
Benjamin M. Davies; bd375{at}cam.ac.uk
↵† TH and ZR contributed equally.
Posted September 13, 2023.
Validity of a smartphone app to objectively monitor performance outcomes in degenerative cervical myelopathy: an observational study
